Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How's the ice cream venture going these days? And the gummies and the big honey deal remember that. Lol
There won't be any significant move upwards until the next catalyst of course. Play by play pps changes day in and day out only help day traders and flippers. Longs don't have to micromanage a position like this phenomenal company unless maybe they are neurotic. We know what we own we know it will go up dramatically when the dominoes begin to fall.
There will still be bellyaching even when we reach dollars. Take it in stride. Onward and upward.
Although this board may affect the sp, it would be very miniscule.
No need to worry about daily fluctuations if you are an investor says the good Doctor. On the other hand, constantly worry, worry worry, fret, fret, fret, bellyache, bellyache, bellyache if person is a flipper. Go ENZC
If Dr. Chandra told everyone what he specifically means by saying "it's time to fly", everyone would be bellyaching that he is letting the cat out of the bag. Sheesh
I have to agree with you. I'm new with this stock so still ever learning.
Most everything these days is farmed out to Chinese or other 3rd world manufacturer and slapping a brand name on it.
I'm sure the good doctor means "Time" as a "period" of time. Anyone should know there would be some sort of retrace after several great green days. That does no mean it's not going to fly. Sheesh.
On Twitter~"As of today, together with Enzolytics, we have started the presentation of their product ITV-1 in Central Africa. There are more than 26 million HIV-positive people there - that we hope to help." #enzoimmune
When did you figure that out? LOL
I still believe we will remain stuck inside of the same pattern/same range until they drop the audit and/or something BIG, which will provide the volume/buying pressure needed.
Keep guessing.
Web site for the sale of ENZOIMUNE launching this week or next week.
Harry's father mentioned in his obituary as a world renowned scientist ~
Zhabilov, Dr. Harry
World renowned scientist, born in Sofia, Bulgaria and discover of TNP a nuclear non histone protein which has proven effective in the treatment of AIDS and Herpes, expired May 9, 2002 in South Pasadena, CA from complications of heart disease at age 63. Among his many other appointments and humanitarian awards for contributions to since, Dr. Zhabilov served as head of the Autoimmune Disease Research Laboratory at the National Institute of Antibiotics of Bulgaria from 1975 until his invitation to work in the Unites States. In 1995, Dr. Zhabilov cofounded Viral Genetics, Inc., a California corporation, focused on developing new breakthrough technology associate with TNP. Viral Genetics, Inc. has obtained patents in over 17 countries and has applied for approval of the sale of its technology by the State Drug Administration for the Peoples Republic of China and the Department of Health for the Republic of Mexico. Dr. Zhabilov is survived by his wife, two sons, daughter-in-law, and grandchild.
Published by Los Angeles Times on May 16, 2002.
Hannity just now said on Fox News, Now it's all about monoclonal antibodies."
Baba~Especially now since the supply chain is so screwed up.
Patience.
Reversal finally coming!
I'm glad they incorporated smiling faces I mentioned in a recent post.
Mr. Consumer most likely will not be attracted to ENZOIMUNE. The name is all too scientific. People want something the can relate to like "Immune Booster". That's what the competition calls theirs. "Immune Modulator", well my friend that's another weird term for the average American to wrap their head around. Then there is "IPF" which communicates absolutely nothing to the consumer.
Another problem I see is with the packaging. Half of the front panel is totally blank. There is plenty of room for a smiling face of a satisfied customer. Basically, there is no attention getting material to win over a potential customer.
With all the March hype about brick and mortar nationwide stores with nothing and now. mid April with the promise from an obscure online outlet, it looks like more hype than anything else.
After awhile, "soon" seems to mean never.
This is now looking like a smokescreen to substitute for lack of solid news.
That is correct, Accounting 101
Yes indeed, ENZC is a CLIENT. Very important for some people to understand.
We welcome our new client $ENZC to our group of clients dedicated to increasing shareholder value.
— Securities Attorneys (@TBLF_LawFirm) April 8, 2022
This one PR tells it all.
Later this year" does not include March which is "early this year". The March timeframe that Chandra mentioned probably refers to one on one talks with prospective retail outlets.
Boca Raton, FL — (ReleaseWire) — 02/22/2022 — Enzolytics IPF Immune™, an immune modulator, will be available later this year to American consumers, who, during the pandemic
Read more: https://www.digitaljournal.com/pr/enzolytics-ipf-immune-will-soon-be-available-to-american-consumers#ixzz7LvLiBocL
Great input Coach.
Timothy Yikes in action. There ought to be a law against what this character is doing.
Give it time. This is more than huge. It is CDMO~End to end all the way to market.
Enzolytics, a Texas-based maker of monoclonal antibody drugs, has inked a deal with Samsung Biologics to support and manufacture its investigational new drug treatments for HIV and COVID-19.
Samsung Biologics will produce a stable cell line and other materials for Enzolytics' monoclonal antibodies from facilities in San Francisco and Incheon, South Korea. (Samsung Biologics)
October 7, 2021
https://www.fiercepharma.com/manufacturing/enzolytics-inks-cmo-deal-samsung-for-covid-19-hiv-drugs
Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins and monoclonal antibodies for the treatment of debilitating infectious diseases. The Company is advancing multiple therapeutics targeting numerous infectious diseases. One patented and clinically tested compound, ITV-1 (Immune Therapeutic Vaccine-1), is a suspension of Inactivated Pepsin Fraction (IPF), covered by U.S. Patent Nos. 8,066,982 and 7,479,538. Studies have shown it to be effective in treating HIV/AIDS. IPF is the active component of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has also been shown to modulate the immune system.
The Company is also implementing its proprietary technology to produce fully human monoclonal antibodies (mAbs) against infectious diseases, including HIV, rabies, influenza A, influenza B, tetanus, and diphtheria. Its proprietary methodology, covered in pending U.S. Patent Application Ser. No. 63/245,122 for producing fully human monoclonal antibodies, is currently employed to produce monoclonal antibody therapeutics for numerous infectious diseases, including the Coronavirus (SARS-CoV-2) and HTLV-1.
“Strategy without tactics is the slowest route to victory. Tactics without strategy is the noise before defeat.” -Sun Tzu
— Gaurav Chandra M.D. (@drgauravchandra) March 31, 2022
Enzolytics Annual Report posted #ENZC https://t.co/6PTSgPOsLu
This is one of a dozen reasons why I haven't bailed out.
$ENZC CLONE 3 has been demonstrated in multiple tests and 5 Independent studies to neutralize the HIV virus in 98% of all known varieties world-wide.
— ENZC LONG(ER) 😂 (@EnzcLonger) March 31, 2022
Why should Charles care for his shareholders considering the nasty way some shareholders carry on??
Even if I in a pump'n dump, at I hope that I at least dump at the right time. Lol.
Alpha, just now Googled it to find out~ Wireline logging is the process of using electric instruments to continuously measure the properties of a formation, in order to make decisions about drilling and production operations. Wireline logging is the measurement of downhole formation attributes using special tools or equipment lowered into the borehole.
Pro-life. It's great to see you here. Getting ready for takeoff. Sure miss your enz_ evaluations. Are you still in the en_c family?
How's that honey deal coming along? How about the ice cream venture? LOL
Buckle your seatbelts~
Retailers participating in the March ECRM event include Amazon, Bed, Bath & Beyond, Burlington Stores, Cardinal Health, CVS, Dollar General, Family Dollar, Giant Eagle, GNC, H-E-B, Kinney Drugs, Meijer, Nexcom, Pharmasave, QVC, Ross Stores, Sam’s Clubs, Sprouts Farmers Markets, Vitamin Shoppe, and Walgreens.
That's not the way I understand it. Go ENZC.
Jeff. I remember all too well how DE_N ran on a purported 10 second Covid19 test kit. Come to find out there never was such a kit.
Just added a little more.
This one particular article gives a timeframe of "later this year"
ReleaseWire
February 22, 2022
Science-Backed Immune Booster is Coming in 2022.
Boca Raton, FL — (ReleaseWire) — 02/22/2022 — "Enzolytics IPF Immune™, an immune modulator, will be available later this year to American consumers. . ."
What happened to March??? $ENZC. Boca Raton, FL — (ReleaseWire) — 02/22/2022 — Enzolytics IPF Immune™, an immune modulator, will be available later this year to American
— ENZC LONG(ER) 😂 (@EnzcLonger) February 24, 2022
Read more: https://t.co/YycJpIHBsi
I would like to see Immunity Booster on from panel in a large font. Also, IPF Immune should not appear twice on front panel.
Use the KISS principle. Bring the cookies down to the bottom shelf. Not everybody understands scientific jargon. That's why I believe Immunity Booster should be used in place of Immunity Modulator, at least on the front panel. There is plenty of room on the front panel to put Immunity Booster in large font.
"Later this year" does not include March which is "early this year". The March timeframe that Chandra mentioned probably refers to one on one talks with prospective retail outlets.
Boca Raton, FL — (ReleaseWire) — 02/22/2022 — Enzolytics IPF Immune™, an immune modulator, will be available later this year to American consumers, who, during the pandemic
Read more: https://www.digitaljournal.com/pr/enzolytics-ipf-immune-will-soon-be-available-to-american-consumers#ixzz7LvLiBocL